In the past week, AGL stock has gone down by -3.29%, with a monthly decline of -10.00% and a quarterly plunge of -48.96%. The volatility ratio for the week is 2.61%, and the volatility levels for the last 30 days are 3.79% for Agilon Health Inc The simple moving average for the past 20 days is -1.62% for AGL’s stock, with a -29.64% simple moving average for the past 200 days.
Is It Worth Investing in Agilon Health Inc (NYSE: AGL) Right Now?
The stock has a 36-month beta value of 0.14. Opinions on the stock are mixed, with 4 analysts rating it as a “buy,” 0 as “overweight,” 14 as “hold,” and 0 as “sell.”
The public float for AGL is 302.33M, and at present, short sellers hold a 6.64% of that float. On June 17, 2025, the average trading volume of AGL was 5.37M shares.
AGL) stock’s latest price update
The stock price of Agilon Health Inc (NYSE: AGL) has jumped by 1.15 compared to previous close of 2.18. Despite this, the company has seen a fall of -3.29% in its stock price over the last five trading days. businesswire.com reported 2025-06-09 that WESTERVILLE, Ohio–(BUSINESS WIRE)–agilon health (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, today announced new research demonstrating the promising role of value-based care (VBC) in maintaining primary care for senior patients when supported by agilon health, a VBC-enablement company. The study was published in the May 2025 issue of Health Affairs Scholar. “Primary care is foundational for Medicare beneficiaries, especially those with c.
Analysts’ Opinion of AGL
Many brokerage firms have already submitted their reports for AGL stocks, with Citigroup repeating the rating for AGL by listing it as a “Buy.” The predicted price for AGL in the upcoming period, according to Citigroup is $5 based on the research report published on April 25, 2025 of the current year 2025.
Bernstein, on the other hand, stated in their research note that they expect to see AGL reach a price target of $8.50. The rating they have provided for AGL stocks is “Outperform” according to the report published on April 08th, 2025.
Citigroup gave a rating of “Neutral” to AGL, setting the target price at $2.25 in the report published on January 10th of the current year.
AGL Trading at -33.17% from the 50-Day Moving Average
After a stumble in the market that brought AGL to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -71.47% of loss for the given period.
Insider Trading
Reports are indicating that there were more than several insider trading activities at AGL starting from McLoughlin Karen, who purchase 25,000 shares at the price of $2.20 back on Dec 13 ’24. After this action, McLoughlin Karen now owns 73,166 shares of Agilon Health Inc, valued at $55,085 using the latest closing price.
Battaglia Silvana, the Director of Agilon Health Inc, purchase 25,062 shares at $2.01 during a trade that took place back on Dec 11 ’24, which means that Battaglia Silvana is holding 66,144 shares at $50,269 based on the most recent closing price.
Stock Fundamentals for AGL
Current profitability levels for the company are sitting at:
- -0.05 for the present operating margin
- -0.01 for the gross margin
The net margin for Agilon Health Inc stands at -0.04. The total capital return value is set at -0.55. Equity return is now at value -42.95, with -12.02 for asset returns.
Based on Agilon Health Inc (AGL), the company’s capital structure generated 0.08 points at debt to capital in total, while cash flow to debt ratio is standing at -1.0. The debt to equity ratio resting at 0.08. The interest coverage ratio of the stock is -47.78.
Currently, EBITDA for the company is -218.19 million with net debt to EBITDA at 0.44. When we switch over and look at the enterprise to sales, we see a ratio of 0.14. The receivables turnover for the company is 4.83for trailing twelve months and the total asset turnover is 3.1. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.20.
Conclusion
To sum up, Agilon Health Inc (AGL) has seen a bad performance recently. Analysts have differing views on the stock, with some seeing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
